title: Localization and structural analysis of a conserved pyruvylated epitope in Bacillus anthracis secondary cell wall polysaccharides and characterization of the galactose-deficient wall polysaccharide from avirulent B. anthracis CDC 684.
abstract: Bacillus anthracis CDC 684 is a naturally occurring, avirulent variant and close relative of the highly pathogenic B. anthracis Vollum. Bacillus anthracis CDC 684 contains both virulence plasmids, pXO1 and pXO2, yet is non-pathogenic in animal models, prompting closer scrutiny of the molecular basis of attenuation. We structurally characterized the secondary cell wall polysaccharide (SCWP) of B. anthracis CDC 684 (Ba684) using chemical and NMR spectroscopy analysis. The SCWP consists of a HexNAc trisaccharide backbone having identical structure as that of B. anthracis Pasteur, Sterne and Ames, →4)-β-d-ManpNAc-(1 → 4)-β-d-GlcpNAc-(1 → 6)-α-d-GlcpNAc-(1→. Remarkably, although the backbone is fully polymerized, the SCWP is the devoid of all galactosyl side residues, a feature which normally comprises 50% of the glycosyl residues on the highly galactosylated SCWPs from pathogenic strains. This observation highlights the role of defective wall assembly in virulence and indicates that polymerization occurs independently of galactose side residue attachment. Of particular interest, the polymerized Ba684 backbone retains the substoichiometric pyruvate acetal, O-acetate and amino group modifications found on SCWPs from normal B. anthracis strains, and immunofluorescence analysis confirms that SCWP expression coincides with the ability to bind the surface layer homology (SLH) domain containing S-layer protein extractable antigen-1. Pyruvate was previously demonstrated as part of a conserved epitope, mediating SLH-domain protein attachment to the underlying peptidoglycan layer. We find that a single repeating unit, located at the distal (non-reducing) end of the Ba684 SCWP, is structurally modified and that this modification is present in identical manner in the SCWPs of normal B. anthracis strains. These polysaccharides terminate in the sequence: (S)-4,6-O-(1-carboxyethylidene)-β-d-ManpNAc-(1 → 4)-[3-O-acetyl]-β-d-GlcpNAc-(1 → 6)-α-d-GlcpNH(2)-(1→.
authors.affiliation: Complex Carbohydrate Research Center, University of Georgia, Athens, GA 30602, USA. sforsb@ccrc.uga.edu
authors.forename: L Scott
authors.initials: LS
authors.lastname: Forsberg
authors.forename: Teresa G
authors.initials: TG
authors.lastname: Abshire
authors.forename: Arthur
authors.initials: A
authors.lastname: Friedlander
authors.forename: Conrad P
authors.initials: CP
authors.lastname: Quinn
authors.forename: Elmar L
authors.initials: EL
authors.lastname: Kannenberg
authors.forename: Russell W
authors.initials: RW
authors.lastname: Carlson
mesh_terms: D001408:Bacillus anthracis / Q000276:immunology* / Q000378:metabolism / Q000472:pathogenicity*; D001426:Bacterial Proteins / Q000235:genetics / Q000378:metabolism; D002473:Cell Wall / Q000378:metabolism*; D002478:Cells, Cultured; D000939:Epitopes / Q000276:immunology*; D005455:Fluorescent Antibody Technique; D005690:Galactose / Q000172:deficiency*; D009682:Magnetic Resonance Spectroscopy; D008562:Membrane Glycoproteins / Q000378:metabolism; D010957:Plasmids / Q000235:genetics; D011134:Polysaccharides / Q000378:metabolism*; D019289:Pyruvic Acid / Q000276:immunology*; D014774:Virulence / Q000276:immunology*
chemical_list: D001426:Bacterial Proteins; D000939:Epitopes; D008562:Membrane Glycoproteins; D011134:Polysaccharides; C055764:S-layer proteins; D019289:Pyruvic Acid; D005690:Galactose